A general assay platform to study protein pharmacology using ligand-dependent structural dynamicsjeanfrancoismaison3 days ago1 min readRated NaN out of 5 stars.https://pubmed.ncbi.nlm.nih.gov/40346061/
In vivo RNAi screen and validation reveals Ngp, Hba-a1, and S100a8 as novel inhibitory targets on T lymphocytes in liver cancerhttps://pubmed.ncbi.nlm.nih.gov/40352930/
Emerging therapeutics targeting tumor-associated macrophages for the treatment of solid organ cancershttps://pubmed.ncbi.nlm.nih.gov/40353504/
Comments